Danimer Scientific (Danimer Scientific) ROCE % : -17.76% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Danimer Scientific ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Danimer Scientific's annualized ROCE % for the quarter that ended in Dec. 2023 was -17.76%.

Danimer Scientific ROCE % Historical Data

The historical data trend for Danimer Scientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danimer Scientific ROCE % Chart

Danimer Scientific Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-9.43

-5.19

-15.40

-16.73

-18.28

Danimer Scientific Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial												-17.12	-17.80	-16.78	-17.37	-17.76

Danimer Scientific ROCE % Calculation

Danimer Scientific's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-125.185	/	( ( (712.27 - 25.287)	+	(698.131 - 15.723) )	/ 2 )
	=	-125.185	/	( (686.983	+	682.408)	/ 2 )
	=	-125.185	/	684.6955
	=	-18.28 %

Danimer Scientific's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-123.328	/	( ( (720.966 - 14.767)	+	(698.131 - 15.723) )	/ 2 )
	=	-123.328	/	( ( 706.199	+	682.408 )	/ 2 )
	=	-123.328	/	694.3035
	=	-17.76 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Danimer Scientific (NYSE:DNMR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Danimer Scientific ROCE % Related Terms

Thank you for viewing the detailed overview of Danimer Scientific's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Danimer Scientific (Danimer Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Danimer Scientific Inc (NYSE:DNMR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

6CU:Germany

Address

140 Industrial Boulevard, Bainbridge, GA, USA, 39817

Website

https://www.danimerscientific.com

Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.

Executives

Richard J Hendrix	director	1300 NORTH 17TH STREET, ARLINGTON VA 22209
Scott Tuten	officer: Chief Marketing Officer	286 DOE RUN DRIVE, CAIRO GA 39828
Gregory W. Hunt	director	730 5TH AVENUE, NEW YORK NY 10019
Allison Leopold Tilley	director	1300 NORTH 17TH STREET, ARLINGTON VA 22209
Cynthia R Cohen	director	1401 BRICKELL AVENUE, SUITE 640, C/O STRATEGIC MINDSHARE, MIAMI FL 33131
John P Amboian	director
Michael A Hajost	officer: Chief Financial Officer	C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662
Stephen Croskrey	director, officer: CEO & Chairman of the Board	C/O ARMOR HOLDINGS INC, 1400 MARSH LANDING PARKWAY SUITE 112, JACKSONVILLE FL 32250
Stuart W Pratt	director	303 CONGRESS STREET, BOSTON MA 02210
Van Trump Phillip D	officer: Chief Technology Officer	1466 NORTH DECATUR ROAD, ATLANTA GA 30306
Philip Gregory Calhoun	director	2100 WHITES BRIDGE ROAD, COLQUITT GA 39837
Isao Noda	director	1568 HUNTER ROAD, FAIRFIELD OH 45914
Michael Eric Smith	officer: Chief Operating Officer	2208 WYNDHAM WAY, BAINBRIDGE GA 39819
Christy A Basco	director	206 WINDING HOLLOW LANE, COPPELL TX 75019
Wunderlich Gary Kent Jr	10 percent owner, officer: President, other: President	CLO B. RILEY FINANCIAL, INC.,, 21255 BURBANK BLVD., SUITE 400, WOODLAND CA 91367